Related Experiment Video
Updated: Jan 8, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neurodevelopmental outcomes in children and adults associated with antenatal corticosteroid exposure: a narrative
Luojia Li1, Joanne M Said1,2, Klea Atallah1
1Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Melbourne, Australia.
Insights
Antenatal corticosteroids may impact long-term neurodevelopment in children and adults, with studies showing mixed results. Further research is needed to clarify the benefits and risks of this fetal lung maturation treatment.
Area of Science:
- Perinatology
- Neurodevelopmental Pediatrics
- Pharmacology
Background:
- Preterm birth presents significant risks for newborns, necessitating interventions like antenatal corticosteroids for fetal lung maturation.
- Concerns exist regarding potential long-term neurodevelopmental harms in individuals exposed to antenatal corticosteroids.
- Existing literature presents a complex and inconclusive picture of these associations.
Purpose of the Study:
- To conduct a narrative review of published literature on the associations between antenatal corticosteroid exposure and neurodevelopmental outcomes in children and adults.
- To synthesize evidence on motor, cognitive, neurosensory, and behavioral impairments following antenatal corticosteroid exposure.
Main Methods:
- Systematic search of academic databases (PubMed, Ovid MEDLINE, Ovid Embase) for articles published between 1995 and 2024.
- Inclusion criteria focused on maternal corticosteroid administration and childhood/adulthood neurodevelopmental outcomes.
- Analysis of 15 studies involving over 8.3 million participants, with follow-up assessments ranging from 2 to 31 years.
Main Results:
- Most studies reported either an increased likelihood or no association between antenatal corticosteroid exposure and adverse neurodevelopment.
- Some studies indicated potential benefits, such as reduced risk of cerebral palsy and cognitive impairments.
- Findings were complex, with significant variability across studies and outcomes.
Conclusions:
- The evidence regarding long-term neurodevelopmental outcomes following antenatal corticosteroid exposure is complex and inconclusive.
- Further research is essential to elucidate the precise benefits and risks in diverse clinical scenarios.
- Understanding these associations is crucial for optimizing antenatal care strategies.
Abstract:
Preterm birth poses significant challenges to newborns including the risk for short- and long-term adverse health and developmental outcomes. The use of antenatal corticosteroids for foetal lung maturation is recommended in some clinical contexts to reduce the risk of severe respiratory distress syndrome. However, there remain concerns for potential harms to long-term neurodevelopment in children and adults exposed to antenatal corticosteroids. The aim of this study is to review the published literature regarding the associations of antenatal corticosteroids with neurodevelopmental outcomes in children and adults. Neurodevelopmental outcomes of interest included motor, cognitive, neurosensory and behavioural impairments. Academic databases were searched for articles published from 1995 to 2024, including PubMed, Ovid MEDLINE and Ovid Embase. The search focused on two domains: (1) maternal corticosteroid administration and (2) neurodevelopmental outcomes in childhood and adulthood. Fifteen studies met the inclusion criteria after full-text screening, comprising 8,343,723 participants of whom at least 0.6% received antenatal corticosteroids. The follow-up age at neurodevelopmental assessment ranged from 2 years' corrected age to 31 years. Most studies reported either an increased likelihood, or no association, of adverse neurodevelopment in antenatal corticosteroids-exposed children and adults. Several studies reported potential benefits, including reductions in risk for cerebral palsy and mild, moderate and unspecified cognitive impairment.Conclusion: This narrative review showed a complex and inconclusive picture regarding the evidence for long-term neurodevelopmental outcomes of antenatal corticosteroid exposure in children and adults. The findings suggest a need for further studies to better understand the potential benefits and risks of antenatal corticosteroids in various clinical contexts.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Factors Affecting Drug Response: Overview
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...